Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS (IPSC) FOR THE EFFICIENT GENERATION OF HYPOIMMUNOGENEIC CHIMERIC ANTIGEN RECEPTOR (CAR)-ENGINEERED T CELLS
Nianias, A., Katsarou, A., Prins, H-J., Shahrabi, A., van Velzen, C., Groen, R., Mutis, T. & Themeli, M., 2022, In: Experimental Hematology. 111, p. S118-S118Research output: Contribution to journal › Meeting Abstract › Academic
-
Modakafusp Alfa (TAK-573), a Novel CD38-Targeting Attenuated Interferon-Alpha Immunocytokine, Kills MM Cells Via NK Cell Activation
Bruins, WSC., Rentenaar, R., Collins, S., Sampson, J., van de Donk, NWCJ., Zweegman, S. & Mutis, T., 15 Nov 2022, In: Blood.Research output: Contribution to journal › Meeting Abstract › Academic
-
Preclinical Activity of Allogeneic CS1-Specific CAR T-Cells (UCARTCS1) in Multiple Myeloma
Mutis, T., Korst, CLBM., Bruins, WSC., Cosovic, M., Verkleij, CPM., Twickler, I., Le Clerre, D., Chion-Sotinel, I., Zweegman, S., Galetto, R. & van de Donk, NWCJ., 15 Nov 2022, In: Blood.Research output: Contribution to journal › Meeting Abstract › Academic
-
Tumour Escape from CAR-T Cells
Rasche, L., Vago, L., Mutis, T., Kröger, N., Gribben, J., Yakoub-Agha, I. & Einsele, H., 7 Feb 2022, In: The EBMT/EHA CAR-T Cell Handbook [internet] .Research output: Contribution to journal › Article › Academic › peer-review
-
Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant
Holthof, L. C., Stikvoort, A., van der Horst, H. J., Gelderloos, A. T., Poels, R., Li, F., Groen, R. W. J., Zweegman, S., van de Donk, N. W. C. J., O'Dwyer, M. & Mutis, T., May 2021, In: HemaSphere. 5, 5, p. e561Research output: Contribution to journal › Article › Academic › peer-review
Open Access